| Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature C Savva, J Adhikaree, S Madhusudan, K Chokkalingam Journal of Diabetes & Metabolic Disorders 18, 267-272, 2019 | 24 | 2019 |
| The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response G Barone, A Arora, A Ganesh, T Abdel-Fatah, P Moseley, R Ali, SYT Chan, ... Oncotarget 9 (50), 29508, 2018 | 16 | 2018 |
| Evaluation of health related quality of life in patients with metabolic syndrome D Tziallas, C Kastanioti, K Savvas, MS Kostapanos, V Tziallas, ... Health Science Journal 6 (1), 116, 2012 | 15 | 2012 |
| Werner syndrome protein expression in breast cancer C Savva, M Sadiq, O Sheikh, S Karim, S Trivedi, AR Green, EA Rakha, ... Clinical Breast Cancer 21 (1), 57-73. e7, 2021 | 11 | 2021 |
| Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers C Savva, K De Souza, R Ali, EA Rakha, AR Green, S Madhusudan Breast Cancer Research and Treatment 175, 105-115, 2019 | 11 | 2019 |
| Primary esophagogastric neuroendocrine carcinoma: a retrospective study from the Nottingham Upper Gastrointestinal Cancer Center C Savva, P Kaye, I Soomro, SL Parsons, E James, S Madhusudan Journal of Gastrointestinal Cancer 49, 85-92, 2018 | 8 | 2018 |
| Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2+ breast carcinoma CN Birts, C Savva, SA Laversin, A Lefas, J Krishnan, A Schapira, ... Scientific Reports 12 (1), 7802, 2022 | 7 | 2022 |
| Obesity is associated with immunometabolic changes in adipose tissue that may drive treatment resistance in breast cancer: immune-metabolic reprogramming and novel therapeutic … C Savva, E Copson, PWM Johnson, RI Cutress, SA Beers Cancers 15 (9), 2440, 2023 | 5 | 2023 |
| Clinical significance of crown-like structures to trastuzumab response in patients with primary invasive HER2+ breast cancer. C Savva, CN Birts, SA Laversin, A Lefas, J Krishnan, A Schapira, ... Journal of Clinical Oncology 39 (15_suppl), e12533-e12533, 2021 | 1 | 2021 |
| Management of Immunotherapy Related Adverse Effects K DeSouza, C Savva Journal of Cancer Prevention & Current Research 6 (1), 2016 | 1 | 2016 |
| 50 Landmark Papers every Breast Surgeon Should Know L Wyld, R Cutress, J Morgan CRC Press, 2024 | | 2024 |
| # 872 Malignant ovarian germ cell tumours: an international multicentre study to identify new prognostic risk factors S Suyanto, A Bergamini, C Savva, B Kaur, S Saso, C Fotopoulou, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | | 2023 |
| 49P Metformin is associated with increased intratumoural immune infiltrates in patients with primary invasive breast cancer C Savva, C Birts, R Foxall, M Ashton-Key, AM Thompson, S Lord, ... ESMO Open 8 (1), 2023 | | 2023 |
| The impact of crown-like structures and metabolic intervention on immune responses in patients with primary breast cancer C Savva University of Southampton, 2022 | | 2022 |
| P041. Systematic review of surgical and patient reported outcomes of neoadjuvant endocrine therapy for breast cancer B Brett, C Savva, L Davies, M Douek, E Copson, R Cutress European Journal of Surgical Oncology 47 (5), e306-e307, 2021 | | 2021 |
| Ethnic differences in mammographic density and their determinants: A cross-sectional study among Caucasian and Indian women C Savva, Z Aitken, I dos Santos Silva NCRI Cancer Conference, Poster A121, 2013 | | 2013 |
Ramsey CutressUniversity of SouthamptonVerified email at soton.ac.uk
